We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Juxtapapillary Uveal Melanomas Patient Outcomes After Treatment With Proton Irradiation for Peripapillary and Parapapillary Melanomas

Samuel K. Houston, MD; Arnold M. Markoe, MD; H. Culver Boldt, MD; Timothy G. Murray, MD, MBA
Arch Ophthalmol. 2011;129(9):1218-1220. doi:10.1001/archophthalmol.2011.241.
Text Size: A A A
Published online


Treatment of uveal melanoma has favored radiotherapy with radioactive plaques or charged particle irradiation since the Collaborative Ocular Melanoma Study (COMS) showed no significant difference in survival between enucleation and brachytherapy for medium-sized tumors (COMS). The COMS melanoma-specific mortality rates were shown to be 10%, 18%, and 21% at 5, 10, and 12 years, respectively.1 Additionally, local tumor failure rates were reported as 10.3% at 5 years. Certain eyes were excluded from the COMS Medium Tumor Trial owing to the proximity of the uveal melanoma to the optic disc. Tumors were not eligible for enrollment in the COMS Medium Tumor Trial due to proximity to the optic nerve if the tumor was (1) touching the optic disc, or (2) within 2 mm of the optic disc and broad enough to subtend an angle of 90° or greater, drawn from the center of the optic disc. These tumors present unique difficulties in treatment with radiotherapy and pose a high risk of ocular complications. In the COMS study, 9% of patients who were otherwise eligible for study inclusion were excluded owing to tumor proximity to the disc.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Melanoma